Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-50
SponsorTanta University
About this trial
The aim of this study is to compare glue embolization and conservative treatment for pelvic congestion syndrome regarding safety and efficacy.
Eligibility criteria
Qualifiers
Women aged from 30 to 50 years.
Complaining from pelvic congestion syndrome.
Disqualifiers
Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.
Patients who are treated with opiates to reduce pelvic pain in the period before the study.
Patient with history of contrast allergy
Patient with renal impairment
Trial design
Treatments tested in this trial
- Micronized purified flavonoid fraction (Daflon ®)
- Glue embolization
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov